PRWeb 2016-12-08 Bricksave have launched their brand new website as well as their first property in New York City. (PRWEB UK) 8 December 2016... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=566934
- VENCLYXTO (venetoclax) monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL) in the presence of 17p deletion or TP53... ...http://in.advfn.com/news_European-Commission-Grants-Conditional-Marketing-A_73089959.html
TOKYO--( BUSINESS WIRE )-- Astellas Pharma Inc. (Tokyo: 4503, President and CEO: Yoshihiko Hatanaka, the Company) announced that it is holding a... ...https://www.asianhhm.com/pressreleases/astellas-research-development-meeting-highlights
Stem cell transplants are sometimes used to treat lymphoma patients. A significant percentage of lymphoma patients undergoing transplants with... ...http://www.medindia.net/news/genetic-mutations-influence-outcomes-in-lymphoma-patients-who-undergo-transplants-165962-1.htm
How These Biotech Stocks are Faring? -- Celgene, Sarepta Therapeutics, MannKind and Amgen Tuesday, December 06, 2016 NEW YORK , December 6,... ...https://www.pharmafocusasia.com/pressreleases/how-these-biotech-stocks-are-faring-celgene-sarepta-therapeutics-mannkind-and-amgen
Anything and Everything in the field...